Proteostasis Therapeutics Lands $37,000,000 Series B Funding

  • Feed Type
  • Date
    9/9/2015
  • Company Name
    Proteostasis Therapeutics
  • Mailing Address
    200 Technology Square 4th Floor Cambridge, MA 02139 USA
  • Company Description
    Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s Proteostasis Network, which maintains the body’s natural protein homeostasis to protect us from numerous diseases.
  • Website
    http://www.proteostasis.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $37,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The company plans to use the proceeds of this financing to advance its lead product candidate in cystic fibrosis into human clinical studies and continue to expand its product portfolio.
  • M&A Terms
  • Venture Investor
    Cormorant Asset Management
  • Venture Investor
    Rock Springs Capital
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    HealthCare Ventures
  • Venture Investor
    Fidelity BioSciences
  • Venture Investor
    Novartis BioVenture Fund
  • Venture Investor
    Novartis Venture Fund
  • Venture Investor
    Sanofi-Genzyme BioVentures

Trending on Xconomy